Cardiff Oncology (CRDF)
- Current price (08:09 PM Central Europe, Wed 21 Oct 2026): USD 0.96
- 24‑hour change: +4.49 %
- Shares outstanding: 77.8 million
- Market capitalization: USD 68.9 million
- Volume traded in last 24 hours: USD 553.5 k
- Month‑to‑date performance: -32.12 %
- 200‑day simple moving average: USD 1.52
- 52‑week high: USD 3.31 (26 Dec 2025)
- 52‑week low: USD 0.76 (29 Jul 2026)
Related Stocks – 24‑Hour Performance
| Ticker | 24‑hour change | Current price | Market cap | Notable filing or event |
|---|---|---|---|---|
| LPAA | -0.46 % | USD 10.87 | USD 82.1 m | Amendment to Schedule 13G filed 20 Oct 2026; ownership now below 10 % threshold. |
| USIO | -0.35 % | USD 3.13 | USD 81.5 m | Current report filed 19 Oct 2026; disclosed upcoming investor presentations. |
| ISPR | -4.23 % | USD 1.31 | USD 82 m | No additional filing reported. |
| NDLS | -0.07 % | USD 12.96 | USD 82.6 m | No additional filing reported. |
| AARD | +4.28 % | USD 4.37 | USD 81.9 m | No additional filing reported. |
Company Profile – Cardiff Oncology
Cardiff Oncology, Inc. is a biotechnology firm headquartered in San Diego, United States, focused on developing therapies for solid tumors and hematologic cancers. The company operates within the Health Care sector and serves customers primarily in California. Cardiff Oncology is listed on the Nasdaq stock exchange and maintains its corporate website at www.cardiffoncology.com .
